Combined with the above-mentioned effects of silencing and overexpression of NAT10 in ACHN and Caki1 cells on the malignant biological behavior of ccRCC, it was suggested that in ccRCC, NAT10 could inhibit ferroptosis and promote disease progression. This evidence concerns the gene NAT10 and nonpapillary renal cell carcinoma.